The disclosure relates to medical devices, and, more particularly, to an excimer laser system including a means for authenticating probes to be used with the excimer laser system.
In the medical industry, there are many surgical devices, instruments and systems comprised of individual components that must work together properly to ensure treatment is performed safely and as intended. For example, medical laser systems are used to treat various conditions in various practice areas (i.e., urology, neurology, otorhinolaryngology, general anesthetic ophthalmology, dentistry, gastroenterology, cardiology, gynecology, and thoracic and orthopedic procedures). Medical laser systems consist of a laser unit, which generates laser radiation, and a separate laser probe having an optical fiber adapted to direct laser radiation from the laser, through the fiber and to the treatment area.
Specific components of a laser system can be designed by a manufacturer to be utilized with other specific components. For example, there are a variety of medical optical fibers available in the marketplace that can be used with laser systems. Currently available laser systems may provide laser light at various wavelengths and thus may be used for particular purposes and procedures. As such, optical fibers to be used with these laser systems may have varying sizes (diameter, length, etc.), be made of various materials, operate at various temperatures, operate at various wavelengths, and have physical characteristics (e.g., bend radii). Specific components of a laser system can be designed by a manufacturer to be utilized with other specific components. For example, there are many varieties of medical optical fibers available in the marketplace that can be used with laser systems that are used in medical procedures. Furthermore, the manufacturer of one component may also manufacture other components of a laser system, or may certify that these other components can be used with the manufacturer's own components.
Prior to beginning a medical procedure, it is important that the proper optical fiber be connected to the laser unit that is to be used for the medical procedure. Oftentimes, the manufacturer of the laser unit recommends usage of particular brands of optical fibers and/or particular optical fibers with the laser unit. When one of the components being used is not a certified product, the full capabilities of the system may not be achieved and may further cause malfunctions, endangering patient safety. For example use of an improper optical fiber can result in damage to the equipment, delay in conducting a medical procedure until the proper optical fiber is obtained, and/or result in the potential for an ineffective, damaging, or potentially life-threatening medical procedure.
The present invention provides a system for authenticating laser probes for use with a laser system. In such a system, the elements generally include a laser unit and single-use, disposable laser probes to be coupled to the laser unit, each laser probe having an optical fiber adapted to direct laser radiation from the laser unit, through the fiber, and to the treatment area. The laser unit comprises a control system for operating the laser unit, including controlling output of laser radiation to a laser probe coupled to the laser unit. The laser unit further includes a means for authenticating any given laser probe to determine whether the laser probe is suitable and/or authorized to operate with the laser unit. In particular, the laser unit includes an RFID reader for reading data embedded in an RFID tag associated with the laser probe upon attachment of the laser probe to the laser unit. The data from the RFID tag is analyzed by the control system and a determination is made as to whether the laser probe is authentic (i.e., suitable for use with the laser unit). In the event that the laser probe is determined to be authentic, the control system allows for transmission of laser radiation to the laser probe and thus a procedure can be performed using the laser probe. In the event that the laser probe is determined to not be authentic, the control system prevents transmission of laser radiation to the laser probe.
The authentication analysis is based on a correlation of the RFID tag data with known, predefined authentication data stored in a database, either locally in the laser unit, or stored in a remote database. The known, predefined authentication data is controlled by the owner/manufacturer of the laser unit, such that the owner/manufacturer can determine what laser probes are to be used with the laser unit. The owner/manufacturer may set a specific authentication key or provide for specific identity numbers that are proprietary to the owner/manufacturer. As such, the RFID tag data for any given laser probe must include a corresponding unique identifier (i.e., authentication key or identity number) in order to be deemed authentic. The RFID tag data may include other information and/or characteristics associated with the laser probe and optical fiber. For example, in some embodiments, the RFID tag data further includes operational history information of the laser probe. As such, in some embodiments, it is further possible to utilize the control system to deauthenticate a laser probe based on operational history, such as in the event that the probe has already been used and/or reached the suggested maximum number of laser pulses, thereby preventing further use of the laser probe with the laser unit.
Accordingly, the authentication system of the present invention ensures that only authorized laser probes are able to be used with the laser unit. The authentication ensures that only those laser probes recommended and authorized by a manufacturer are to be used, thereby ensuring that the laser system functions as intended and patient safety is maintained. The authentication further protects against the use of counterfeit components. As counterfeit proprietary components become more prevalent, the need to authenticate original products becomes increasingly necessary. By embedding RFID directly into the laser probe and utilizing RFID technology for authentication, manufacturers can foil counterfeiters and secure recurring revenue streams, which may otherwise be lost due to counterfeit products.
The invention provides a system for authenticating laser probes for use with a laser system. In such a system, the elements generally include a laser unit and single-use, disposable laser probes to be coupled to the laser unit, each laser probe having an optical fiber adapted to direct laser radiation from the laser unit, through the fiber, and to the treatment area. The laser unit comprises a control system for operating the laser unit, including controlling output of laser radiation to a laser probe coupled to the laser unit. The laser unit further includes a means for authenticating any given laser probe to determine whether the laser probe is suitable and/or authorized to operate with the laser unit. In particular, the laser unit includes an RFID reader for reading data embedded in an RFID tag associated with the laser probe upon attachment of the laser probe to the laser unit. The data from the RFID tag is analyzed by the control system and a determination is made as to whether the laser probe is authentic (i.e., suitable for use with the laser unit). In the event that the laser probe is determined to be authentic, the control system allows for transmission of laser radiation to the laser probe and thus a procedure can be performed using the laser probe. In the event that the laser probe is determined to not be authentic, the control system prevents transmission of laser radiation to the laser probe.
Accordingly, the authentication system of the present invention ensures that only authorized laser probes are able to be used with the laser unit. The authentication ensures that only those laser probes recommended and authorized by a manufacturer are to be used, thereby ensuring that the laser system functions as intended and patient safety is maintained. The authentication further protects against the use of counterfeit components. As counterfeit proprietary components become more prevalent, the need to authenticate original products becomes increasingly necessary. By embedding RFID directly into the laser probe and utilizing RFID technology for authentication, manufacturers can foil counterfeiters and secure recurring revenue streams, which may otherwise be lost due to counterfeit products.
The laser unit and laser probe of the present invention is particularly well suited for intraocular procedures in which laser treatment of target tissues is desired. In particular, the laser probe and laser unit of the present invention is preferably used for treating glaucoma and useful in performing a laser trabeculostomy. However, it should be noted that a laser probe consistent with the present disclosure can be used in any laser treatment of various conditions, including other eye conditions (i.e., diabetic eye diseases, such as proliferative diabetic retinopathy or macular oedema, cases of age-related macular degeneration, retinal tears, and retinopathy of prematurity, and laser-assisted in situ keratomileusis (LASIK) to correct refractive errors, such as short-sightedness (myopia) or astigmatism) as well as other conditions in general and other practice areas (non-ocular practice areas).
The laser source 108 may include an excimer laser 110 and a gas cartridge 112 for providing the appropriate gas combination to the laser 110. The excimer laser 110 is a form of ultraviolet laser that generally operates in the UV spectral region and generates nanosecond pulses. The excimer gain medium (i.e., the medium contained within the gas cartridge 114) is generally a gas mixture containing a noble gas (e.g., argon, krypton, or xenon) and a reactive gas (e.g., fluorine or chlorine). Under the appropriate conditions of electrical stimulation and high pressure, a pseudo-molecule called an excimer (or in the case of noble gas halides, exciplex) is created, which can only exist in an energized state and can give rise to laser light in the UV range.
Laser action in an excimer molecule occurs because it has a bound (associative) excited state, but a repulsive (dissociative) ground state. Noble gases such as xenon and krypton are highly inert and do not usually form chemical compounds. However, when in an excited state (induced by electrical discharge or high-energy electron beams), they can form temporarily bound molecules with themselves (excimer) or with halogens (exciplex) such as fluorine and chlorine. The excited compound can release its excess energy by undergoing spontaneous or stimulated emission, resulting in a strongly repulsive ground state molecule which very quickly (on the order of a picosecond) dissociates back into two unbound atoms. This forms a population inversion. The excimer laser 110 of the present system 100 is an XeCl excimer laser and emits a wavelength of 308 nm.
The controller 104 provides an operator (i.e., surgeon or other medical professional) with control over the output of laser signals (from the laser source 108 to the fiber core 204) and, in turn, control over the transmission of laser energy from the fiber core 204 of the probe 200. However, prior to providing an operator with control over laser output, the laser probe 200 undergoes an authentication procedure to determine whether the laser probe 200 is in fact suitable for use with the laser unit system 100. In particular, upon coupling the laser prober 200 to the system 100, the RFID reader 102 reads data embedded in the RFID tag 202 of the laser probe 200, wherein such RFID tag data is analyzed to determine authenticity of the laser probe 200.
The controller 104 may include software, firmware and/or circuitry configured to perform any of the aforementioned operations. Software may be embodied as a software package, code, instructions, instruction sets and/or data recorded on non-transitory computer readable storage medium. Firmware may be embodied as code, instructions or instruction sets and/or data that are hard-coded (e.g., nonvolatile) in memory devices. “Circuitry”, as used in any embodiment herein, may comprise, for example, singly or in any combination, hardwired circuitry, programmable circuitry such as computer processors comprising one or more individual instruction processing cores, state machine circuitry, and/or firmware that stores instructions executed by programmable circuitry. For example, the controller 104 may include a hardware processor coupled to non-transitory, computer-readable memory containing instructions executable by the processor to cause the controller to carry out various functions of the laser system 100 as described herein, including controller laser and/or illumination output.
The authentication analysis is based on a correlation of the RFID tag data with known, predefined authentication data stored in a database, either a local database (i.e., probe database 114) forming part of the laser unit system 100, or a remote database hosted via a remote server 300 (i.e., probe database 302). For example, in some embodiments, the system 100 may communicate and exchange data with a remote server 300 over a network. The network may represent, for example, a private or non-private local area network (LAN), personal area network (PAN), storage area network (SAN), backbone network, global area network (GAN), wide area network (WAN), or collection of any such computer networks such as an intranet, extranet or the Internet (i.e., a global system of interconnected network upon which various applications or service run including, for example, the World Wide Web).
The known, predefined authentication data stored in the database (database 114 or database 302) may be controlled by the owner/manufacturer of the laser unit 100, for example, such that the owner/manufacturer can determine what laser probes are to be used with the laser unit. For example, the owner/manufacturer may set a specific authentication key or provide for specific identity numbers that are proprietary to the owner/manufacturer. As such, the RFID tag data for any given laser probe must include a corresponding unique identifier (i.e., authentication key or identity number) in order to be deemed authentic.
One approach to uniquely identifying a laser probe is to authenticate the probe by using a private key. In such an approach, both the laser system 100 and the RFID tag 202 are taught an identical key. The RFID tag 202 and laser system 100 then operate in conjunction to authenticate the key. More specifically, the laser system 100 generates a random, unique challenge number. The RFID tag 202 uses this challenge, in combination with the key to generate a response of an authentication code. The method for generating this code (known as a hash function) masks the value of the key. Another approach to uniquely identifying a laser probe is to use unique and unchangeable identity numbers. This approach can be used if there is a region of memory (e.g., a serial or model number), that can only be written by the RFID manufacturer. The protection is realized by ensuring that the manufacturer only provides tags with legal identification numbers, which prevents simple duplication of legitimate tags.
The RFID tag data may include other information and/or characteristics associated with the laser probe and optical fiber. For example, in some embodiments, the RFID tag data further includes operational history information of the laser probe. As such, in some embodiments, it is further possible to utilize the controller 104 to deauthenticate a laser probe based on operational history, such as in the event that the probe has already been used and/or reached the suggested maximum number of laser pulses, thereby preventing further use of the laser probe with the laser unit.
As generally understood, RFID technology uses electromagnetic fields to automatically identify and track tags attached to objects. As previously noted, the RFID tag associated with the laser probe contains electronically-stored information. The RFID tag may either be read-only, having a factory-assigned serial number that is used as a key into a database, or may be read/write, where object-specific data can be written into the tag by the system user. Field programmable tags may be write-once, read-multiple; “blank” tags may be written with an electronic product code by the user. The RFID tag contains at least three parts: an integrated circuit that stores and processes information and that modulates and demodulates radio-frequency (RF) signals; a means of collecting DC power from the incident reader signal; and an antenna for receiving and transmitting the signal. The tag information is stored in a non-volatile memory. The RFID tag includes either fixed or programmable logic for processing the transmission and sensor data, respectively.
The RFID reader transmits an encoded radio signal to interrogate the tag. The RFID tag receives the message and then responds with its identification and other information. This may be only a unique tag serial number, or may be product-related information such as a stock number, lot or batch number, production date, or other specific information. Since tags have individual serial numbers, the RFID system design can discriminate among several tags that might be within the range of the RFID reader and read them simultaneously.
In some embodiments, the RFID tag may be a passive tag, which collects energy from the RFID reader of the laser system interrogating radio waves. In some embodiments, the RFID tag may be an active tag, which includes a local power source (e.g., a battery) and may operate hundreds of meters from the RFID reader of the laser system.
Accordingly, the authentication system of the present invention ensures that only authorized laser probes are able to be used with the laser unit. The authentication ensures that only those laser probes recommended and authorized by a manufacturer are to be used, thereby ensuring that the laser system functions as intended and patient safety is maintained. The authentication further protects against the use of counterfeit components. As counterfeit proprietary components become more prevalent, the need to authenticate original products becomes increasingly necessary. By embedding RFID directly into the laser probe and utilizing RFID technology for authentication, manufacturers can foil counterfeiters and secure recurring revenue streams, which may otherwise be lost due to counterfeit products.
As used in any embodiment herein, the term “module” may refer to software, firmware and/or circuitry configured to perform any of the aforementioned operations. Software may be embodied as a software package, code, instructions, instruction sets and/or data recorded on non-transitory computer readable storage medium. Firmware may be embodied as code, instructions or instruction sets and/or data that are hard-coded (e.g., nonvolatile) in memory devices. “Circuitry”, as used in any embodiment herein, may comprise, for example, singly or in any combination, hardwired circuitry, programmable circuitry such as computer processors comprising one or more individual instruction processing cores, state machine circuitry, and/or firmware that stores instructions executed by programmable circuitry. The modules may, collectively or individually, be embodied as circuitry that forms part of a larger system, for example, an integrated circuit (IC), system on-chip (SoC), desktop computers, laptop computers, tablet computers, servers, smart phones, etc.
Any of the operations described herein may be implemented in a system that includes one or more storage mediums having stored thereon, individually or in combination, instructions that when executed by one or more processors perform the methods. Here, the processor may include, for example, a server CPU, a mobile device CPU, and/or other programmable circuitry.
Also, it is intended that operations described herein may be distributed across a plurality of physical devices, such as processing structures at more than one different physical location. The storage medium may include any type of tangible medium, for example, any type of disk including hard disks, floppy disks, optical disks, compact disk read-only memories (CD-ROMs), compact disk rewritables (CD-RWs), and magneto-optical disks, semiconductor devices such as read-only memories (ROMs), random access memories (RAMs) such as dynamic and static RAMs, erasable programmable read-only memories (EPROMs), electrically erasable programmable read-only memories (EEPROMs), flash memories, Solid State Disks (SSDs), magnetic or optical cards, or any type of media suitable for storing electronic instructions. Other embodiments may be implemented as software modules executed by a programmable control device. The storage medium may be non-transitory.
As described herein, various embodiments may be implemented using hardware elements, software elements, or any combination thereof. Examples of hardware elements may include processors, microprocessors, circuits, circuit elements (e.g., transistors, resistors, capacitors, inductors, and so forth), integrated circuits, application specific integrated circuits (ASIC), programmable logic devices (PLD), digital signal processors (DSP), field programmable gate array (FPGA), logic gates, registers, semiconductor device, chips, microchips, chip sets, and so forth.
Reference throughout this specification to “one embodiment” or “an embodiment” means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment. Thus, appearances of the phrases “in one embodiment” or “in an embodiment” in various places throughout this specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments.
The term “non-transitory” is to be understood to remove only propagating transitory signals per se from the claim scope and does not relinquish rights to all standard computer-readable media that are not only propagating transitory signals per se. Stated another way, the meaning of the term “non-transitory computer-readable medium” and “non-transitory computer-readable storage medium” should be construed to exclude only those types of transitory computer-readable media which were found in In Re Nuijten to fall outside the scope of patentable subject matter under 35 U.S.C. § 101.
The terms and expressions which have been employed herein are used as terms of description and not of limitation, and there is no intention, in the use of such terms and expressions, of excluding any equivalents of the features shown and described (or portions thereof), and it is recognized that various modifications are possible within the scope of the claims. Accordingly, the claims are intended to cover all such equivalents.
References and citations to other documents, such as patents, patent applications, patent publications, journals, books, papers, web contents, have been made throughout this disclosure. All such documents are hereby incorporated herein by reference in their entirety for all purposes.
Various modifications of the invention and many further embodiments thereof, in addition to those shown and described herein, will become apparent to those skilled in the art from the full contents of this document, including references to the scientific and patent literature cited herein. The subject matter herein contains important information, exemplification and guidance that can be adapted to the practice of this invention in its various embodiments and equivalents thereof.
This application is a continuation patent application of U.S. application Ser. No. 16/389,346, filed Apr. 19, 2019, now granted as U.S. Pat. No. 11,076,933, the entire disclosure of which is hereby incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
4607622 | Fritch et al. | Aug 1986 | A |
4846172 | Berlin | Jul 1989 | A |
4862888 | Yessik | Sep 1989 | A |
5281241 | Patel | Jan 1994 | A |
5323766 | Uram | Jun 1994 | A |
5738677 | Colvard et al. | Apr 1998 | A |
5755716 | Garito et al. | May 1998 | A |
5865831 | Cozean et al. | Feb 1999 | A |
6197056 | Schachar | Mar 2001 | B1 |
6283974 | Alexander | Sep 2001 | B1 |
6743221 | Hobart et al. | Jun 2004 | B1 |
7443296 | Mezhinsky et al. | Oct 2008 | B2 |
7568619 | Todd et al. | Aug 2009 | B2 |
7801271 | Gertner et al. | Sep 2010 | B2 |
9489785 | Klammer et al. | Nov 2016 | B2 |
9642746 | Berlin | May 2017 | B2 |
10383689 | Berlin | Aug 2019 | B2 |
11076933 | Junger et al. | Aug 2021 | B2 |
11076992 | Junger et al. | Aug 2021 | B2 |
11103382 | Junger et al. | Aug 2021 | B2 |
11234866 | Junger et al. | Feb 2022 | B2 |
11389239 | Junger et al. | Jul 2022 | B2 |
11464677 | Junger et al. | Oct 2022 | B2 |
11529260 | Junger et al. | Dec 2022 | B2 |
20020013572 | Berlin | Jan 2002 | A1 |
20020183726 | Elbrecht et al. | Dec 2002 | A1 |
20040082939 | Berlin | Apr 2004 | A1 |
20040114879 | Hiereth et al. | Jun 2004 | A1 |
20040147985 | MacFarland et al. | Jul 2004 | A1 |
20050192480 | Toriya et al. | Sep 2005 | A1 |
20050283148 | Janssen et al. | Dec 2005 | A1 |
20060111699 | Neuberger | May 2006 | A1 |
20060244652 | Tethrake | Nov 2006 | A1 |
20070027443 | Rose et al. | Feb 2007 | A1 |
20070122096 | Temelkuran et al. | May 2007 | A1 |
20070147752 | Weisberg et al. | Jun 2007 | A1 |
20070219601 | Neuberger | Sep 2007 | A1 |
20070265602 | Mordaunt et al. | Nov 2007 | A1 |
20080054073 | Charles | Mar 2008 | A1 |
20080082078 | Berlin | Apr 2008 | A1 |
20080097415 | Zimare et al. | Apr 2008 | A1 |
20080108981 | Telfair et al. | May 2008 | A1 |
20080108983 | Nadolski | May 2008 | A1 |
20080161781 | McArdle et al. | Jul 2008 | A1 |
20080269734 | Vila Echague et al. | Oct 2008 | A1 |
20090030300 | Hhaboussi et al. | Jan 2009 | A1 |
20090118715 | Mansour | May 2009 | A1 |
20090157064 | Hodel | Jun 2009 | A1 |
20100019125 | Stefani et al. | Jan 2010 | A1 |
20100068141 | Kaushal et al. | Mar 2010 | A1 |
20100324543 | Kurtz et al. | Dec 2010 | A1 |
20110295243 | Peyman | Dec 2011 | A1 |
20110301507 | Romano et al. | Dec 2011 | A1 |
20120275481 | Riggs | Nov 2012 | A1 |
20130041357 | Neuberger | Feb 2013 | A1 |
20130085484 | Van Valen et al. | Apr 2013 | A1 |
20140058367 | Dantus | Feb 2014 | A1 |
20140188096 | Chia et al. | Jul 2014 | A1 |
20140276603 | Magee et al. | Sep 2014 | A1 |
20140316388 | Hipsley | Oct 2014 | A1 |
20150051607 | Hajishah et al. | Feb 2015 | A1 |
20150080783 | Berlin | Mar 2015 | A1 |
20150148615 | Brennan et al. | May 2015 | A1 |
20150217133 | Angeley et al. | Aug 2015 | A1 |
20150297408 | Dolzan et al. | Oct 2015 | A1 |
20150305811 | Neuberger | Oct 2015 | A1 |
20150366706 | Belkin et al. | Dec 2015 | A1 |
20150374549 | Scott | Dec 2015 | A1 |
20170100041 | Kasamatsu et al. | Apr 2017 | A1 |
20170202708 | Berlin | Jul 2017 | A1 |
20170304001 | Searle et al. | Oct 2017 | A1 |
20180000337 | Chen et al. | Jan 2018 | A1 |
20180042772 | Mansour | Feb 2018 | A1 |
20180263647 | Aljuri | Sep 2018 | A1 |
20180271703 | Hallen | Sep 2018 | A1 |
20180303667 | Peyman | Oct 2018 | A1 |
20180353328 | Bacher et al. | Dec 2018 | A1 |
20180360310 | Berlin | Dec 2018 | A1 |
20190105200 | Hipsley | Apr 2019 | A1 |
20190117459 | Berlin | Apr 2019 | A1 |
20190262071 | Thom et al. | Aug 2019 | A1 |
20200078216 | Raksi | Mar 2020 | A1 |
20200078217 | Raksi | Mar 2020 | A1 |
20200330157 | Junger et al. | Oct 2020 | A1 |
20200330181 | Junger et al. | Oct 2020 | A1 |
20200330266 | Junger et al. | Oct 2020 | A1 |
20200330274 | Junger et al. | Oct 2020 | A1 |
20200330275 | Junger et al. | Oct 2020 | A1 |
20200330279 | Junger et al. | Oct 2020 | A1 |
20200330280 | Junger et al. | Oct 2020 | A1 |
20200330281 | Junger et al. | Oct 2020 | A1 |
20200390600 | Perera et al. | Dec 2020 | A1 |
20210235986 | Juhasz et al. | Aug 2021 | A1 |
20210259880 | Newton et al. | Aug 2021 | A1 |
20210298945 | Juhasz et al. | Sep 2021 | A1 |
20220022997 | Junger et al. | Jan 2022 | A1 |
20220023098 | Junger et al. | Jan 2022 | A1 |
20220031513 | Junger et al. | Feb 2022 | A1 |
20220151828 | Junger et al. | May 2022 | A1 |
20220183882 | Mosaed et al. | Jun 2022 | A1 |
20220183887 | Junger et al. | Jun 2022 | A1 |
20220280343 | Junger et al. | Sep 2022 | A1 |
20220387107 | Junger et al. | Dec 2022 | A1 |
20220387218 | Junger et al. | Dec 2022 | A1 |
Number | Date | Country |
---|---|---|
19920615 | Dec 2000 | DE |
10023176 | Nov 2001 | DE |
10138984 | Mar 2003 | DE |
1835862 | Jun 2011 | EP |
2120760 | Sep 2015 | EP |
2019060756 | Mar 2019 | WO |
2020215062 | Oct 2020 | WO |
2020215064 | Oct 2020 | WO |
2020215066 | Oct 2020 | WO |
2020215067 | Oct 2020 | WO |
2020215068 | Oct 2020 | WO |
2020215069 | Oct 2020 | WO |
2020215071 | Oct 2020 | WO |
20200215073 | Oct 2020 | WO |
Entry |
---|
Berlin et al., “Excimer Laser Trabeculostomy: An Effective Microinvasive Glaucoma Surgery Procedure for Open-Angle Glaucoma”, published Dec. 19, 2013 Third Party Submission in 010503. |
Dietlein et al., “Erbium: YAG Laser Trabecular Ablation (LTA) in the Surgical Treatment of Glaucoma”, Lasers in Surgery and Medicine, Jan. 6, 1999, vol. 23, pp. 104-110. |
ExTra Operating Instructions, Manufacturer: Mlase AG, published prior to Jan. 1, 2018. |
Francis et al., “Combined Cataract Extraction and Trabeculotomy by the Internal Approach for Coexisting Cataract and Open-Angle Glaucoma: Initial Results”, Journal of Cataract & Refractive Surgery, Jul. 1, 2008, vol. 34, pp. 1096-1103. |
Investigation Testing Authorization Application, TUI Laser AG, Published Jan. 1, 2016. |
Wilmsmeyer et al., “Excimer Laser Trabeculotomy: A New, Minimally Invasive Procedure for Patients With Glaucoma”, Graefe's Archive for Clinical and Experimental Ophthalmology, Oct. 19, 2005, vol. 244, pp. 670-676. |
Crandall, Alan, “Combining Cataract and Glaucoma Surgery”, Review of Ophthalmology, 1-4, Jun. 13, 2008. |
Grover, Davinder S. “When You Have Cataracts and Glaucoma”, Glaucoma Research Foundation, Oct. 29, 2017. |
Taliaferro, Kevin et al. “Excimer Laser Trabeculostomy Normalizing IOP and Restoring Physiologic Outflow in Glaucoma.” Glaucoma Today, 2009, pp. 45-47 (Year: 2009). |
Toteberg-Harms, et al., “Cataract surgery combined with excimer laser trabeculotomy to lower intraocular pressure: effectiveness dependent on preoperative IOP.” BMC ophthalmology, vol. 13, No. 1, p. 24 (2013). |
Tsai, James C. “High Eye Pressure and Glaucoma”, Glaucoma Research Foundation, Oct. 29, 2017. |
International Search Report in International Application No. PCT/US2020/028962 dated Jun. 2, 2020. |
Leung et al., “Anterior Chamber Angle Measurement with Anterior Segment Optical Coherence Tomography: A Comparison between Slit Lamp OCT and Visante OCT” IOVS, pp. 3469-3474, Aug. 2008. |
U.S. Appl. No. 16/389,404 US20200330275A1, filed Apr. 19, 2019 Oct. 22, 2020, Combination Treatment Using Phaco and ELT. |
U.S. Appl. No. 16/389,437 US20200330281A1, filed Apr. 19, 2019 Oct. 22, 2020, Excimer Laser Fiber Illumination. |
U.S. Appl. No. 16/389,359 US20200330279A1, filed Apr. 19, 2019 Oct. 22, 2020, Calibration System for Improving Manufacture Tolerance in Excimer Laser Optical Fibers. |
U.S. Appl. No. 16/389,446 US20200330266A1, filed Apr. 19, 2019 Oct. 22, 2020, Combination Treatment Using ELT. |
U.S. Appl. No. 16/389,460 US20200330274A1, filed Apr. 19, 2019 Oct. 22, 2020, Methods of Transverse Placement in ELT. |
U.S. Appl. No. 16/389,425 US20200330280A1, filed Apr. 19, 2019 Oct. 22, 2020, Personalization of Excimer Laser Fibers. |
U.S. Appl. No. 16/389,386 US20200330157A1, filed Apr. 19, 2019 Oct. 22, 2020, Enhances Fiber Probes for ELT. |
MLase AG, ExTra Operating Instructions (Apr. 2016). |
MLase AG, Specifications FIDO Laser applicator for ExTra Laser system (Jul. 13, 2012). |
MLase AG, Specifications FIDO laser applicator for ExTra Laser System (Sep. 26, 2013). |
MLase AG, Specifications FIDO laser applicator for ExTra Laser System, dated Sep. 26, 2013. |
Investigation Testing Authorization Application, TUI Laser AG, 43 pages, published prior to Jan. 1, 2018. |
Number | Date | Country | |
---|---|---|---|
20220022997 A1 | Jan 2022 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16389346 | Apr 2019 | US |
Child | 17363656 | US |